U-shaped relationship of HDL and risk of infectious disease: two prospective population-based cohort studies
Abstract Aims Preclinical evidence has indicated that HDL may play an important role in the immune system; however, very little is known about the role of HDL in the immune system in humans. We tested the hypothesis that low and high concentrations of HDL cholesterol are associated with risk of infe...
Saved in:
Published in | European heart journal Vol. 39; no. 14; pp. 1181 - 1190 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
England
Oxford University Press
07.04.2018
|
Subjects | |
Online Access | Get full text |
ISSN | 0195-668X 1522-9645 1522-9645 |
DOI | 10.1093/eurheartj/ehx665 |
Cover
Abstract | Abstract
Aims
Preclinical evidence has indicated that HDL may play an important role in the immune system; however, very little is known about the role of HDL in the immune system in humans. We tested the hypothesis that low and high concentrations of HDL cholesterol are associated with risk of infectious disease in the general population.
Methods and results
We included 97 166 individuals from the Copenhagen General Population Study and 9387 from the Copenhagen City Heart Study with measurements of HDL cholesterol at baseline. The primary endpoint was any infectious disease requiring hospital admission, ascertained in the Danish health registries from baseline in 2003–13 or 1991–94 through 2014; 9% and 31% of individuals in the two studies experienced one or more infectious disease events. Using restricted cubic splines, there was a U-shaped association between concentrations of HDL cholesterol and risk of any infection. Following multifactorial adjustment, individuals with HDL cholesterol below 0.8 mmol/L (31 mg/dL) and above 2.6 mmol/L (100 mg/dL) had hazard ratios for any infection of 1.75 (95% confidence interval 1.31–2.34) and 1.43 (1.16–1.76), compared to those with HDL cholesterol of 2.2–2.3 mmol/L (85–95 mg/dL). In the Copenhagen City Heart Study, corresponding hazard ratios for any infection were 2.00 (1.16–3.43) and 1.13 (0.80–1.60).
Conclusion
Low and high HDL cholesterol concentrations found in 21% and 8% of individuals were associated with higher risk of infectious disease in the general population. These findings do not necessarily indicate causality. |
---|---|
AbstractList | Preclinical evidence has indicated that HDL may play an important role in the immune system; however, very little is known about the role of HDL in the immune system in humans. We tested the hypothesis that low and high concentrations of HDL cholesterol are associated with risk of infectious disease in the general population.AimsPreclinical evidence has indicated that HDL may play an important role in the immune system; however, very little is known about the role of HDL in the immune system in humans. We tested the hypothesis that low and high concentrations of HDL cholesterol are associated with risk of infectious disease in the general population.We included 97 166 individuals from the Copenhagen General Population Study and 9387 from the Copenhagen City Heart Study with measurements of HDL cholesterol at baseline. The primary endpoint was any infectious disease requiring hospital admission, ascertained in the Danish health registries from baseline in 2003-13 or 1991-94 through 2014; 9% and 31% of individuals in the two studies experienced one or more infectious disease events. Using restricted cubic splines, there was a U-shaped association between concentrations of HDL cholesterol and risk of any infection. Following multifactorial adjustment, individuals with HDL cholesterol below 0.8 mmol/L (31 mg/dL) and above 2.6 mmol/L (100 mg/dL) had hazard ratios for any infection of 1.75 (95% confidence interval 1.31-2.34) and 1.43 (1.16-1.76), compared to those with HDL cholesterol of 2.2-2.3 mmol/L (85-95 mg/dL). In the Copenhagen City Heart Study, corresponding hazard ratios for any infection were 2.00 (1.16-3.43) and 1.13 (0.80-1.60).Methods and resultsWe included 97 166 individuals from the Copenhagen General Population Study and 9387 from the Copenhagen City Heart Study with measurements of HDL cholesterol at baseline. The primary endpoint was any infectious disease requiring hospital admission, ascertained in the Danish health registries from baseline in 2003-13 or 1991-94 through 2014; 9% and 31% of individuals in the two studies experienced one or more infectious disease events. Using restricted cubic splines, there was a U-shaped association between concentrations of HDL cholesterol and risk of any infection. Following multifactorial adjustment, individuals with HDL cholesterol below 0.8 mmol/L (31 mg/dL) and above 2.6 mmol/L (100 mg/dL) had hazard ratios for any infection of 1.75 (95% confidence interval 1.31-2.34) and 1.43 (1.16-1.76), compared to those with HDL cholesterol of 2.2-2.3 mmol/L (85-95 mg/dL). In the Copenhagen City Heart Study, corresponding hazard ratios for any infection were 2.00 (1.16-3.43) and 1.13 (0.80-1.60).Low and high HDL cholesterol concentrations found in 21% and 8% of individuals were associated with higher risk of infectious disease in the general population. These findings do not necessarily indicate causality.ConclusionLow and high HDL cholesterol concentrations found in 21% and 8% of individuals were associated with higher risk of infectious disease in the general population. These findings do not necessarily indicate causality. Abstract Aims Preclinical evidence has indicated that HDL may play an important role in the immune system; however, very little is known about the role of HDL in the immune system in humans. We tested the hypothesis that low and high concentrations of HDL cholesterol are associated with risk of infectious disease in the general population. Methods and results We included 97 166 individuals from the Copenhagen General Population Study and 9387 from the Copenhagen City Heart Study with measurements of HDL cholesterol at baseline. The primary endpoint was any infectious disease requiring hospital admission, ascertained in the Danish health registries from baseline in 2003–13 or 1991–94 through 2014; 9% and 31% of individuals in the two studies experienced one or more infectious disease events. Using restricted cubic splines, there was a U-shaped association between concentrations of HDL cholesterol and risk of any infection. Following multifactorial adjustment, individuals with HDL cholesterol below 0.8 mmol/L (31 mg/dL) and above 2.6 mmol/L (100 mg/dL) had hazard ratios for any infection of 1.75 (95% confidence interval 1.31–2.34) and 1.43 (1.16–1.76), compared to those with HDL cholesterol of 2.2–2.3 mmol/L (85–95 mg/dL). In the Copenhagen City Heart Study, corresponding hazard ratios for any infection were 2.00 (1.16–3.43) and 1.13 (0.80–1.60). Conclusion Low and high HDL cholesterol concentrations found in 21% and 8% of individuals were associated with higher risk of infectious disease in the general population. These findings do not necessarily indicate causality. Preclinical evidence has indicated that HDL may play an important role in the immune system; however, very little is known about the role of HDL in the immune system in humans. We tested the hypothesis that low and high concentrations of HDL cholesterol are associated with risk of infectious disease in the general population. We included 97 166 individuals from the Copenhagen General Population Study and 9387 from the Copenhagen City Heart Study with measurements of HDL cholesterol at baseline. The primary endpoint was any infectious disease requiring hospital admission, ascertained in the Danish health registries from baseline in 2003-13 or 1991-94 through 2014; 9% and 31% of individuals in the two studies experienced one or more infectious disease events. Using restricted cubic splines, there was a U-shaped association between concentrations of HDL cholesterol and risk of any infection. Following multifactorial adjustment, individuals with HDL cholesterol below 0.8 mmol/L (31 mg/dL) and above 2.6 mmol/L (100 mg/dL) had hazard ratios for any infection of 1.75 (95% confidence interval 1.31-2.34) and 1.43 (1.16-1.76), compared to those with HDL cholesterol of 2.2-2.3 mmol/L (85-95 mg/dL). In the Copenhagen City Heart Study, corresponding hazard ratios for any infection were 2.00 (1.16-3.43) and 1.13 (0.80-1.60). Low and high HDL cholesterol concentrations found in 21% and 8% of individuals were associated with higher risk of infectious disease in the general population. These findings do not necessarily indicate causality. |
Author | Tybjærg-Hansen, Anne Nordestgaard, Børge G Frikke-Schmidt, Ruth Varbo, Anette Madsen, Christian M |
Author_xml | – sequence: 1 givenname: Christian M surname: Madsen fullname: Madsen, Christian M organization: Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev Ringvej 75, 2730 Herlev, Denmark – sequence: 2 givenname: Anette surname: Varbo fullname: Varbo, Anette organization: Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev Ringvej 75, 2730 Herlev, Denmark – sequence: 3 givenname: Anne surname: Tybjærg-Hansen fullname: Tybjærg-Hansen, Anne organization: The Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev Ringvej 75, 2730 Herlev, Denmark – sequence: 4 givenname: Ruth surname: Frikke-Schmidt fullname: Frikke-Schmidt, Ruth organization: The Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev Ringvej 75, 2730 Herlev, Denmark – sequence: 5 givenname: Børge G surname: Nordestgaard fullname: Nordestgaard, Børge G email: boerge.nordestgaard@regionh.dk organization: Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev Ringvej 75, 2730 Herlev, Denmark |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29228167$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkTlPxDAQhS0EguXoqZBLJBSwnWSc0KHllFaiYSW6yOtMFEM2DrbD8e_JkoWCAirLnu_NPM_bJZutbZGQQ85OOcvjM-xdjcqFpzOs3wHSDTLhqRBRDkm6SSaM52kEkD3ukF3vnxhjGXDYJjsiFyLjICekmUe-Vh2W1GGjgrGtr01HbUVvL2dUtcO78c-ru2kr1APQe1oaj8rjOQ1vlnbO-m5VeUXa2a4fu0SLASiptrV1gfrQlwb9PtmqVOPxYH3ukfn11cP0Nprd39xNL2aRThgPUR4zFeuMcUh0JbioFihRykzpUidZqkAAq2QSl1hBqnkmRQYgF1KUaSwkyHiPHI99B28vPfpQLI3X2DSqxcF_wXMJjIk4WaFHa7RfLLEsOmeWyn0U3xsaADYCevind1j9IJwVqxCKnxCKMYRBAr8k2oSvrQSnTPOX8GQU2r77f8wn4JCg9g |
CitedBy_id | crossref_primary_10_3389_fphar_2021_720283 crossref_primary_10_1097_MOL_0000000000000589 crossref_primary_10_1186_s13045_020_00963_6 crossref_primary_10_3389_fneur_2022_891622 crossref_primary_10_1024_1661_8157_a003241 crossref_primary_10_1186_s12944_022_01638_6 crossref_primary_10_3389_fcvm_2020_00039 crossref_primary_10_51789_cmsj_2021_1_e13 crossref_primary_10_1016_j_lanwpc_2023_100874 crossref_primary_10_1093_eurheartj_ehz962 crossref_primary_10_1007_s11657_019_0579_0 crossref_primary_10_1016_j_jacl_2021_10_005 crossref_primary_10_1002_jmv_29794 crossref_primary_10_1007_s15027_017_1275_x crossref_primary_10_3389_fnut_2024_1430835 crossref_primary_10_1161_ATVBAHA_120_314050 crossref_primary_10_1124_jpet_119_261719 crossref_primary_10_1016_j_gastha_2021_12_009 crossref_primary_10_1016_j_numecd_2021_06_016 crossref_primary_10_1186_s13054_023_04589_1 crossref_primary_10_1002_jmv_70207 crossref_primary_10_1097_MOL_0000000000000612 crossref_primary_10_1016_j_athplu_2025_02_001 crossref_primary_10_1097_MOL_0000000000000577 crossref_primary_10_1016_j_pmedr_2021_101461 crossref_primary_10_1161_ATVBAHA_120_315669 crossref_primary_10_1253_circj_CJ_20_0348 crossref_primary_10_1016_j_numecd_2022_10_001 crossref_primary_10_1016_j_plipres_2021_101092 crossref_primary_10_3343_alm_2022_42_4_415 crossref_primary_10_1016_j_jacc_2022_10_019 crossref_primary_10_1016_j_pathol_2018_09_062 crossref_primary_10_1161_CIRCULATIONAHA_120_050808 crossref_primary_10_3390_jcm10245955 crossref_primary_10_1186_s12879_024_10125_5 crossref_primary_10_1016_j_ebiom_2024_104981 crossref_primary_10_1093_jalm_jfaa002 crossref_primary_10_14309_ajg_0000000000002179 crossref_primary_10_1161_ATVBAHA_120_314983 crossref_primary_10_1016_j_ijcard_2018_11_095 crossref_primary_10_1080_07853890_2024_2400312 crossref_primary_10_29058_mjwbs_1432328 crossref_primary_10_1016_j_cjca_2019_03_016 crossref_primary_10_1097_MOL_0000000000000563 crossref_primary_10_1186_s12985_022_01865_4 crossref_primary_10_1093_cvr_cvac194 crossref_primary_10_1093_cvr_cvad043 crossref_primary_10_1017_S0007114519001429 crossref_primary_10_61186_aassjournal_1300 crossref_primary_10_1371_journal_pgen_1009713 crossref_primary_10_1371_journal_pone_0210808 crossref_primary_10_1136_bjo_2024_326062 crossref_primary_10_1161_CIRCULATIONAHA_120_048568 crossref_primary_10_1016_j_addr_2020_10_006 crossref_primary_10_1097_MD_0000000000036288 crossref_primary_10_2139_ssrn_4074563 crossref_primary_10_1093_cvr_cvy198 crossref_primary_10_1093_eurheartj_ehy187 crossref_primary_10_31612_2616_4868_6_2024_17 crossref_primary_10_1016_j_cca_2020_07_015 crossref_primary_10_1016_j_beem_2022_101689 crossref_primary_10_1053_j_jrn_2020_09_002 crossref_primary_10_3389_fcvm_2022_989428 crossref_primary_10_1016_j_bbalip_2021_159063 crossref_primary_10_1002_ijc_34164 crossref_primary_10_1016_j_amjcard_2021_11_041 crossref_primary_10_1111_imm_13348 crossref_primary_10_1016_j_arteri_2021_11_006 crossref_primary_10_1007_s10096_019_03543_w crossref_primary_10_1016_j_ebiom_2022_104166 crossref_primary_10_1038_s41598_025_90766_x crossref_primary_10_1186_s12944_020_01382_9 crossref_primary_10_1016_j_bbalip_2021_159058 crossref_primary_10_1161_ATVBAHA_119_313381 crossref_primary_10_1016_j_atherosclerosis_2018_06_881 crossref_primary_10_1093_cvr_cvab164 crossref_primary_10_20945_2359_3997000000585 crossref_primary_10_1164_rccm_201806_1157OC crossref_primary_10_1097_MOL_0000000000000705 crossref_primary_10_1016_j_beem_2023_101751 crossref_primary_10_1186_s12986_020_00455_x crossref_primary_10_3746_pnf_2023_28_3_263 crossref_primary_10_52727_2078_256X_2022_18_2_117_128 crossref_primary_10_32604_biocell_2023_031063 crossref_primary_10_1016_j_rec_2022_10_001 crossref_primary_10_1016_j_jlr_2024_100728 crossref_primary_10_1016_S2213_8587_19_30264_5 crossref_primary_10_1186_s12902_024_01758_3 crossref_primary_10_1007_s42000_018_0058_9 crossref_primary_10_7554_eLife_75170 crossref_primary_10_3390_ijms23158128 crossref_primary_10_1016_j_atherosclerosis_2021_12_009 crossref_primary_10_1016_j_bbadis_2025_167761 crossref_primary_10_1097_MOL_0000000000000899 crossref_primary_10_3892_etm_2023_12350 crossref_primary_10_51789_cmsj_2022_2_e5 crossref_primary_10_1002_iid3_861 crossref_primary_10_1080_10409238_2021_1925217 crossref_primary_10_1016_j_athplu_2023_01_002 crossref_primary_10_1038_s41598_020_71921_y crossref_primary_10_3390_ijms21030739 crossref_primary_10_1186_s12889_025_22251_z crossref_primary_10_15420_usc_2019_3_2 crossref_primary_10_5551_jat_63894 crossref_primary_10_1016_j_amjmed_2020_07_022 crossref_primary_10_3390_nu10060764 crossref_primary_10_1161_ATVBAHA_119_313651 crossref_primary_10_1373_clinchem_2018_299636 crossref_primary_10_1186_s12933_024_02447_0 crossref_primary_10_5551_jat_47183 crossref_primary_10_1016_j_tem_2020_01_003 crossref_primary_10_1097_MOL_0000000000000642 crossref_primary_10_1161_ATVBAHA_118_310727 crossref_primary_10_1093_eurheartj_ehac605 crossref_primary_10_1161_STROKEAHA_121_034393 crossref_primary_10_1093_eurheartj_ehz502 crossref_primary_10_1111_cts_13462 crossref_primary_10_1097_CCM_0000000000004519 crossref_primary_10_3390_ijms23179777 crossref_primary_10_2174_0929867326666190201142321 crossref_primary_10_3390_ijms22094547 crossref_primary_10_1002_hep4_1745 crossref_primary_10_1016_j_artere_2022_05_002 crossref_primary_10_1210_clinem_dgab095 crossref_primary_10_3390_cells10051041 crossref_primary_10_3390_cells10051061 crossref_primary_10_1111_imm_13260 crossref_primary_10_1093_cvr_cvz127 crossref_primary_10_1016_j_jlr_2021_100067 crossref_primary_10_3389_fmed_2024_1333472 crossref_primary_10_1016_j_jlr_2021_100061 crossref_primary_10_1038_s41598_019_57373_z crossref_primary_10_1093_eurheartj_ehx734 crossref_primary_10_3390_biomedicines10092320 crossref_primary_10_1016_j_recesp_2022_08_004 crossref_primary_10_1186_s12937_024_00983_9 crossref_primary_10_1007_s11883_020_00902_3 crossref_primary_10_3390_jcm13237242 crossref_primary_10_1016_j_ijbiomac_2023_124342 crossref_primary_10_1177_2047487319848214 |
Cites_doi | 10.1093/eurheartj/ehx274 10.2337/db14-1603 10.1016/j.jacc.2012.08.1026 10.1136/bmj.g4379 10.1093/eurheartj/ehx163 10.1161/01.CIR.101.16.1907 10.1084/jem.180.3.1025 10.1097/01.CCM.0000171183.79525.6B 10.1159/000347077 10.1016/j.jcrc.2014.04.018 10.1093/eurheartj/ehw272 10.1038/nature14462 10.1054/clnu.2002.0575 10.1007/s00125-006-0570-3 10.1038/nature01461 10.1001/jama.299.21.2524 10.1016/j.atherosclerosis.2012.07.029 10.1093/eurheartj/ehw152 10.1056/NEJMoa0706628 10.1074/jbc.M112.442699 10.1161/CIRCRESAHA.115.306249 10.1161/ATVBAHA.106.136325 10.2307/30141957 10.1016/S0735-1097(03)00407-8 10.1093/cvr/cvu150 10.1126/science.1189731 10.1111/j.1365-2362.2010.02269.x 10.1126/science.aad3517 10.1007/s00392-007-0611-z |
ContentType | Journal Article |
Copyright | Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2017. For permissions, please email: journals.permissions@oup.com. 2017 |
Copyright_xml | – notice: Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2017. For permissions, please email: journals.permissions@oup.com. 2017 |
DBID | AAYXX CITATION NPM 7X8 |
DOI | 10.1093/eurheartj/ehx665 |
DatabaseName | CrossRef PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
DocumentTitleAlternate | Focus Issue on Lipids |
EISSN | 1522-9645 |
EndPage | 1190 |
ExternalDocumentID | 29228167 10_1093_eurheartj_ehx665 10.1093/eurheartj/ehx665 |
Genre | Journal Article |
GroupedDBID | --- -E4 .2P .I3 .XZ .ZR 08P 0R~ 18M 1TH 29G 2WC 4.4 482 48X 53G 5GY 5RE 5VS 5WA 5WD 70D AABZA AACZT AAJKP AAJQQ AAMVS AAOGV AAPNW AAPQZ AAPXW AARHZ AASNB AAUAY AAUQX AAVAP ABEUO ABIXL ABKDP ABNHQ ABNKS ABOCM ABPTD ABQLI ABQNK ABWST ABXVV ABZBJ ACGFO ACGFS ACPRK ACUFI ACUTJ ACUTO ACYHN ADBBV ADEYI ADEZT ADGZP ADHKW ADHZD ADIPN ADJQC ADOCK ADQBN ADRIX ADRTK ADVEK ADYVW ADZXQ AEGPL AEGXH AEJOX AEKSI AEMDU AENEX AENZO AEPUE AETBJ AEWNT AFFZL AFIYH AFOFC AFXAL AFXEN AGINJ AGKEF AGQXC AGSYK AGUTN AHMBA AHXPO AIAGR AIJHB AJEEA ALMA_UNASSIGNED_HOLDINGS ALUQC APIBT APWMN ATGXG AXUDD BAWUL BAYMD BCGUY BCRHZ BEYMZ BHONS BTRTY BVRKM C45 CDBKE CS3 CZ4 DAKXR DIK DILTD D~K E3Z EBS EE~ EJD EMOBN ENERS F5P F9B FECEO FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC GX1 H13 H5~ HAR HW0 HZ~ IOX J21 KAQDR KBUDW KOP KQ8 KSI KSN L7B M-Z M41 M49 MHKGH ML0 N9A NGC NOMLY NOYVH NU- O9- OAUYM OAWHX OB3 OCZFY ODMLO OGROG OJQWA OJZSN OK1 OPAEJ OVD OWPYF P2P PAFKI PEELM PQQKQ Q1. Q5Y R44 RD5 ROL ROX ROZ RUSNO RW1 RXO SEL TCURE TEORI TJX W8F WOQ X7H YAYTL YKOAZ YXANX ZKX ~91 AAFWJ AAYXX ABDFA ABEJV ABGNP ABJNI ABPQP ABVGC ADGHP ADNBA AEMQT AFYAG AGORE AHMMS AJBYB AJNCP ALXQX CITATION JXSIZ NPM 7X8 |
ID | FETCH-LOGICAL-c401t-930a3c80164cf212fbe7e778acdc485a6260f743def65c18728667b72d5327673 |
ISSN | 0195-668X 1522-9645 |
IngestDate | Thu Jul 10 23:25:18 EDT 2025 Wed Feb 19 02:44:10 EST 2025 Tue Jul 01 01:29:35 EDT 2025 Thu Apr 24 23:07:59 EDT 2025 Wed Sep 11 04:48:09 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 14 |
Keywords | HDL Infectious disease Lipids General population Lipoproteins Epidemiology |
Language | English |
License | This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/about_us/legal/notices) http://academic.oup.com/journals/pages/about_us/legal/notices |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c401t-930a3c80164cf212fbe7e778acdc485a6260f743def65c18728667b72d5327673 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 29228167 |
PQID | 1976002347 |
PQPubID | 23479 |
PageCount | 10 |
ParticipantIDs | proquest_miscellaneous_1976002347 pubmed_primary_29228167 crossref_primary_10_1093_eurheartj_ehx665 crossref_citationtrail_10_1093_eurheartj_ehx665 oup_primary_10_1093_eurheartj_ehx665 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2018-04-07 |
PublicationDateYYYYMMDD | 2018-04-07 |
PublicationDate_xml | – month: 04 year: 2018 text: 2018-04-07 day: 07 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | European heart journal |
PublicationTitleAlternate | Eur Heart J |
PublicationYear | 2018 |
Publisher | Oxford University Press |
Publisher_xml | – name: Oxford University Press |
References | Barter ( key 20180407055350_ehx665-B25) 2007; 357 Madsen ( key 20180407055350_ehx665-B18) 2017; 38 Wurfel ( key 20180407055350_ehx665-B20) 1994; 180 Guo ( key 20180407055350_ehx665-B6) 2013; 288 Catapano ( key 20180407055350_ehx665-B9) 2014; 103 Wang ( key 20180407055350_ehx665-B12) 2012; 225 Rodriguez-Sanz ( key 20180407055350_ehx665-B15) 2013; 35 Lekkou ( key 20180407055350_ehx665-B4) 2014; 29 Frikke-Schmidt ( key 20180407055350_ehx665-B1) 2008; 299 Chien ( key 20180407055350_ehx665-B5) 2005; 33 Vanhamme ( key 20180407055350_ehx665-B8) 2003; 422 Grion ( key 20180407055350_ehx665-B16) 2010; 40 Nordestgaard ( key 20180407055350_ehx665-B19) 2016; 37 Barter ( key 20180407055350_ehx665-B23) 2017; 38 Zanoni ( key 20180407055350_ehx665-B22) 2016; 351 Agerholm-Larsen ( key 20180407055350_ehx665-B24) 2000; 101 Yvan-Charvet ( key 20180407055350_ehx665-B11) 2010; 328 Shor ( key 20180407055350_ehx665-B13) 2008; 97 Benfield ( key 20180407055350_ehx665-B29) 2007; 50 Birjmohun ( key 20180407055350_ehx665-B7) 2007; 27 Keene ( key 20180407055350_ehx665-B3) 2014; 349 Haase ( key 20180407055350_ehx665-B28) 2015; 64 Blaho ( key 20180407055350_ehx665-B10) 2015; 523 Delgado-Rodríguez ( key 20180407055350_ehx665-B14) 1997; 18 Catapano ( key 20180407055350_ehx665-B26) 2016; 37 Nordestgaard ( key 20180407055350_ehx665-B27) 2016; 118 Canturk ( key 20180407055350_ehx665-B17) 2002; 21 Andersen ( key 20180407055350_ehx665-B21) 2003; 41 Varbo ( key 20180407055350_ehx665-B2) 2013; 61 |
References_xml | – volume: 38 start-page: 2487 year: 2017 ident: key 20180407055350_ehx665-B23 article-title: HDL cholesterol concentration or HDL function: which matters? publication-title: Eur Heart J doi: 10.1093/eurheartj/ehx274 – volume: 64 start-page: 3328 year: 2015 ident: key 20180407055350_ehx665-B28 article-title: HDL cholesterol and risk of type 2 diabetes: a Mendelian randomization study publication-title: Diabetes doi: 10.2337/db14-1603 – volume: 61 start-page: 427 year: 2013 ident: key 20180407055350_ehx665-B2 article-title: Remnant cholesterol as a causal risk factor for ischemic heart disease publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2012.08.1026 – volume: 349 start-page: g4379. year: 2014 ident: key 20180407055350_ehx665-B3 article-title: Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients publication-title: BMJ doi: 10.1136/bmj.g4379 – volume: 38 start-page: 2478 year: 2017 ident: key 20180407055350_ehx665-B18 article-title: Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: two prospective cohort studies publication-title: Eur Heart J doi: 10.1093/eurheartj/ehx163 – volume: 101 start-page: 1907 year: 2000 ident: key 20180407055350_ehx665-B24 article-title: Elevated HDL cholesterol is a risk factor for ischemic heart disease in white women when caused by a common mutation in the cholesteryl ester transfer protein gene publication-title: Circulation doi: 10.1161/01.CIR.101.16.1907 – volume: 180 start-page: 1025 year: 1994 ident: key 20180407055350_ehx665-B20 article-title: Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS publication-title: J Exp Med doi: 10.1084/jem.180.3.1025 – volume: 33 start-page: 1688 year: 2005 ident: key 20180407055350_ehx665-B5 article-title: Low serum level of high-density lipoprotein cholesterol is a poor prognostic factor for severe sepsis publication-title: Crit Care Med doi: 10.1097/01.CCM.0000171183.79525.6B – volume: 35 start-page: 291 year: 2013 ident: key 20180407055350_ehx665-B15 article-title: High-density lipoprotein: a novel marker for risk of in-hospital infection in acute ischemic stroke patients? publication-title: Cerebrovasc Dis doi: 10.1159/000347077 – volume: 29 start-page: 723 year: 2014 ident: key 20180407055350_ehx665-B4 article-title: Serum lipid profile, cytokine production, and clinical outcome in patients with severe sepsis publication-title: J Crit Care doi: 10.1016/j.jcrc.2014.04.018 – volume: 37 start-page: 2999 year: 2016 ident: key 20180407055350_ehx665-B26 article-title: 2016 ESC/EAS Guidelines for the management of dyslipidaemias publication-title: Eur Heart J doi: 10.1093/eurheartj/ehw272 – volume: 523 start-page: 342 year: 2015 ident: key 20180407055350_ehx665-B10 article-title: HDL-bound sphingosine-1-phosphate restrains lymphopoiesis and neuroinflammation publication-title: Nature doi: 10.1038/nature14462 – volume: 21 start-page: 431 year: 2002 ident: key 20180407055350_ehx665-B17 article-title: Risk of nosocomial infections and effects of total cholesterol, HDL cholesterol in surgical patients publication-title: Clin Nutr doi: 10.1054/clnu.2002.0575 – volume: 50 start-page: 549 year: 2007 ident: key 20180407055350_ehx665-B29 article-title: Influence of diabetes and hyperglycaemia on infectious disease hospitalisation and outcome publication-title: Diabetologia doi: 10.1007/s00125-006-0570-3 – volume: 422 start-page: 83 year: 2003 ident: key 20180407055350_ehx665-B8 article-title: Apolipoprotein L-I is the trypanosome lytic factor of human serum publication-title: Nature doi: 10.1038/nature01461 – volume: 299 start-page: 2524 year: 2008 ident: key 20180407055350_ehx665-B1 article-title: Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease publication-title: JAMA doi: 10.1001/jama.299.21.2524 – volume: 225 start-page: 105 year: 2012 ident: key 20180407055350_ehx665-B12 article-title: HDL and ApoA-I inhibit antigen presentation-mediated T cell activation by disrupting lipid rafts in antigen presenting cells publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2012.07.029 – volume: 37 start-page: 1944 year: 2016 ident: key 20180407055350_ehx665-B19 article-title: Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine publication-title: Eur Heart J doi: 10.1093/eurheartj/ehw152 – volume: 357 start-page: 2109 year: 2007 ident: key 20180407055350_ehx665-B25 article-title: Effects of torcetrapib in patients at high risk for coronary events publication-title: N Engl J Med doi: 10.1056/NEJMoa0706628 – volume: 288 start-page: 17947 year: 2013 ident: key 20180407055350_ehx665-B6 article-title: High density lipoprotein protects against polymicrobe-induced sepsis in mice publication-title: J Biol Chem doi: 10.1074/jbc.M112.442699 – volume: 118 start-page: 547 year: 2016 ident: key 20180407055350_ehx665-B27 article-title: Triglyceride-rich lipoproteins and atherosclerotic cardiovascular disease: new insights from epidemiology, genetics, and biology publication-title: Circ Res doi: 10.1161/CIRCRESAHA.115.306249 – volume: 27 start-page: 1153 year: 2007 ident: key 20180407055350_ehx665-B7 article-title: High-density lipoprotein attenuates inflammation and coagulation response on endotoxin challenge in humans publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/ATVBAHA.106.136325 – volume: 18 start-page: 9 year: 1997 ident: key 20180407055350_ehx665-B14 article-title: Total cholesterol, HDL-cholesterol, and risk of nosocomial infection: a prospective study in surgical patients. Infect publication-title: Control Hosp Epidemiol doi: 10.2307/30141957 – volume: 41 start-page: 1972 year: 2003 ident: key 20180407055350_ehx665-B21 article-title: Hepatic lipase mutations, elevated high-density lipoprotein cholesterol, and increased risk of ischemic heart disease: the Copenhagen City Heart Study publication-title: J Am Coll Cardiol doi: 10.1016/S0735-1097(03)00407-8 – volume: 103 start-page: 372 year: 2014 ident: key 20180407055350_ehx665-B9 article-title: HDL in innate and adaptive immunity publication-title: Cardiovasc Res doi: 10.1093/cvr/cvu150 – volume: 328 start-page: 1689 year: 2010 ident: key 20180407055350_ehx665-B11 article-title: ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation publication-title: Science doi: 10.1126/science.1189731 – volume: 40 start-page: 330 year: 2010 ident: key 20180407055350_ehx665-B16 article-title: Lipoproteins and CETP levels as risk factors for severe sepsis in hospitalized patients publication-title: Eur J Clin Invest doi: 10.1111/j.1365-2362.2010.02269.x – volume: 351 start-page: 1166 year: 2016 ident: key 20180407055350_ehx665-B22 article-title: Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease publication-title: Science doi: 10.1126/science.aad3517 – volume: 97 start-page: 227 year: 2008 ident: key 20180407055350_ehx665-B13 article-title: Low HDL levels and the risk of death, sepsis and malignancy publication-title: Clin Res Cardiol doi: 10.1007/s00392-007-0611-z |
SSID | ssj0008616 |
Score | 2.5937912 |
Snippet | Abstract
Aims
Preclinical evidence has indicated that HDL may play an important role in the immune system; however, very little is known about the role of HDL... Preclinical evidence has indicated that HDL may play an important role in the immune system; however, very little is known about the role of HDL in the immune... |
SourceID | proquest pubmed crossref oup |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1181 |
Title | U-shaped relationship of HDL and risk of infectious disease: two prospective population-based cohort studies |
URI | https://www.ncbi.nlm.nih.gov/pubmed/29228167 https://www.proquest.com/docview/1976002347 |
Volume | 39 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Zj9MwELbKIiFeEDflkpH2Ba1MN3ESO7ytgFU5lhe2aN8ix3boXmmVbcXxG_jRjM-my4IWXqI0Se3W82U8nvlmjNCmUoBaUZTERPlIJqkmHKYBIphOG85EUtiiPnsfi_Eke3eQHwwGP3uspeWifiF_XJhX8j9ShWsgV5Ml-w-SjY3CBTgH-cIRJAzHS8l4Qs6mYq6Vz0jx1Cvjmn_9YY04HihXy7MQkbF8jq8zw88KyZZb87iZFzGTm8l3m4J1bkvQBq7heSe-2RB7sdX_tda9rbxjx9UuMEokeng-i652uTVtpBkZ18H3-shG7YvuCxmL1jew067i_rvd4fGxJp_k9PRQ2cnD8PP7fouEW7qLm1u117WwDi4LV00yKGNX2SiALuupVpMhe6HOd_Ww9LKz__jInE-_FW4Hih4I5qcWBWmZpjwp2Gr-i6zEcOsKupoysMSMif32fZzXeZGEQDd0OYodjlx3pqy0b2DNxlnLm_xt-WLNmP2b6IZff-AdB6ZbaKDb2-janmdY3EEnAVO4jyk8azBgCgOmsMGU-bzCFPaYeokBUbiHKHweUdghCntE3UWT3Tf7r8bE78hBJKzDF6Sk24JKbsqyyQaMnqbWTDPGhVQy47kwq-MGbFKlmyKXCWcpvPisZqnKKQwpo_fQRjtr9QOEtZZpKjIplKRZzhpOqdoWEoZQZUrmYohGYQwr6cvVm11TTipHm6BVFEDlBDBEz-M35q5Uy1-e3QSxXOKxZ0FuFahdE0sTrYaBrZLSRrRpxobovhNobC3A4OEf7zxC11evxGO0seiW-gkYt4v6qcXcL0mirFM |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=U-shaped+relationship+of+HDL+and+risk+of+infectious+disease%3A+two+prospective+population-based+cohort+studies&rft.jtitle=European+heart+journal&rft.au=Madsen%2C+Christian+M&rft.au=Varbo%2C+Anette&rft.au=Tybj%C3%A6rg-Hansen%2C+Anne&rft.au=Frikke-Schmidt%2C+Ruth&rft.date=2018-04-07&rft.eissn=1522-9645&rft.volume=39&rft.issue=14&rft.spage=1181&rft_id=info:doi/10.1093%2Feurheartj%2Fehx665&rft_id=info%3Apmid%2F29228167&rft.externalDocID=29228167 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0195-668X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0195-668X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0195-668X&client=summon |